<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id>
<journal-id journal-id-type="publisher-id">BPH</journal-id>
<journal-title-group>
<journal-title>British Journal of Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1188</issn>
<issn pub-type="epub">1476-5381</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28214378</article-id>
<article-id pub-id-type="pmc">5980403</article-id>
<article-id pub-id-type="doi">10.1111/bph.13747</article-id>
<article-id pub-id-type="publisher-id">BPH13747</article-id>
<article-id pub-id-type="other">2016-BJP-0981-RCT-G.R1</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Themed Section: Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Calcium signalling through L‐type calcium channels: role in pathophysiology of spinal nociceptive transmission</article-title>
<alt-title alt-title-type="right-running-head">L‐type calcium channels and pain pathophysiology</alt-title>
<alt-title alt-title-type="left-running-head">O Roca‐Lapirot et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="bph13747-cr-0001">
<name>
<surname>Roca‐Lapirot</surname>
<given-names>Olivier</given-names>
</name>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13747-cr-0002">
<name>
<surname>Radwani</surname>
<given-names>Houda</given-names>
</name>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13747-cr-0003">
<name>
<surname>Aby</surname>
<given-names>Franck</given-names>
</name>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13747-cr-0004">
<name>
<surname>Nagy</surname>
<given-names>Frédéric</given-names>
</name>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13747-cr-0005">
<name>
<surname>Landry</surname>
<given-names>Marc</given-names>
</name>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph13747-cr-0006">
<name>
<surname>Fossat</surname>
<given-names>Pascal</given-names>
</name>
<address>
<email>pascal.fossat@u-bordeaux.fr</email>
</address>
<xref ref-type="aff" rid="bph13747-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bph13747-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Interdisciplinary Institute for Neuroscience (IINS, CNRS UMR 5297)</named-content>
<institution>University of Bordeaux</institution>
<named-content content-type="city">Bordeaux Cedex</named-content>
<country country="FR">France</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Pascal Fossat, PhD, Interdisciplinary Institute for Neuroscience (IINS), University of Bordeaux, CNRS UMR5297. 146 rue Leo Saignat, 33076 Bordeaux Cedex, France. E‐mail: <email>pascal.fossat@u-bordeaux.fr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<volume>175</volume>
<issue>12</issue>
<issue-id pub-id-type="doi">10.1111/bph.v175.12</issue-id>
<issue-title content-type="special-issue-title">Themed Section: Recent Advances in Targeting Ion Channels to Treat Chronic Pain. Guest Editors: Edward B Stevens and Gary J Stephens</issue-title>
<fpage>2362</fpage>
<lpage>2374</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BPH-175-2362.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="bph13747-sec-1051">
<p>L‐type voltage‐gated calcium channels are ubiquitous channels in the CNS. L‐type calcium channels (LTCs) are mostly post‐synaptic channels regulating neuronal firing and gene expression. They play a role in important physio‐pathological processes such as learning and memory, Parkinson's disease, autism and, as recognized more recently, in the pathophysiology of pain processes. Classically, the fundamental role of these channels in cardiovascular functions has limited the use of classical molecules to treat LTC‐dependent disorders. However, when applied locally in the dorsal horn of the spinal cord, the three families of LTC pharmacological blockers – dihydropyridines (nifedipine), phenylalkylamines (verapamil) and benzothiazepines (diltiazem) – proved effective in altering short‐term sensitization to pain, inflammation‐induced hyperexcitability and neuropathy‐induced allodynia. Two subtypes of LTCs, Ca<sub>v</sub>1.2 and Ca<sub>v</sub>1.3, are expressed in the dorsal horn of the spinal cord, where Ca<sub>v</sub>1.2 channels are localized mostly in the soma and proximal dendritic shafts, and Ca<sub>v</sub>1.3 channels are more distally located in the somato‐dendritic compartment. Together with their different kinetics and pharmacological properties, this spatial distribution contributes to their separate roles in shaping short‐ and long‐term sensitization to pain. Ca<sub>v</sub>1.3 channels sustain the expression of plateau potentials, an input/output amplification phenomenon that contributes to short‐term sensitization to pain such as prolonged after‐discharges, dynamic receptive fields and windup. The Ca<sub>v</sub>1.2 channels support calcium influx that is crucial for the excitation‐transcription coupling underlying nerve injury‐induced dorsal horn hyperexcitability. These subtype‐specific cellular mechanisms may have different consequences in the development and/or the maintenance of pathological pain. Recent progress in developing more specific compounds for each subunit will offer new opportunities to modulate LTCs for the treatment of pathological pain with reduced side‐effects.</p>
</sec>
<sec id="bph13747-sec-0051">
<title>Linked Articles</title>
<p>This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit <ext-link ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc">http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc</ext-link>
</p>
</sec>
</abstract>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<page-count count="13"></page-count>
<word-count count="6289"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bph13747</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:31.05.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bph13747-cit-0000" publication-type="journal">
<string-name>
<surname>Roca‐Lapirot</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Radwani</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Aby</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Nagy</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Landry</surname>, <given-names>M.</given-names>
</string-name>, and <string-name>
<surname>Fossat</surname>, <given-names>P.</given-names>
</string-name> (<year>2018</year>) <article-title>Calcium signalling through L‐type calcium channels: role in pathophysiology of spinal nociceptive transmission</article-title>. <source xml:lang="en"/>British Journal of Pharmacology, <volume>175</volume>: <fpage>2362</fpage>–<lpage>2374</lpage>. doi: <ext-link ext-link-type="doi" xlink:href="10.1111/bph.13747">10.1111/bph.13747</ext-link>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>